| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |